Thermo Fisher Scientific Inc · NYSE:TMO
Casper Marc N sold 4,883 Thermo Fisher Scientific Inc shares (Form 4)
Traded Aug 7, 2026 · Filed Aug 10, 2026
On Aug 7, 2026, Casper Marc N (Director, Chairman & CEO) sold 4,883 Thermo Fisher Scientific Inc shares at an average US$586.12 for US$2.86M under a trading plan, leaving 0 shares. Filed Aug 10, 2026 (Form 4).
- Sold
- 4,883 shares
- Price
- US$586.12 average (US$577.37 to US$593.32)
- Value
- US$2.86M
- Holding after
- 0 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chairman & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Common Stock | Option exercise | 275 | US$309.63 | 124,200 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 6 | US$577.37 | 124,194 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 4 | US$579.26 | 124,190 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 2 | US$579.27 | 124,188 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 4 | US$580.71 | 124,184 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 3 | US$580.72 | 124,181 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 5 | US$581.85 | 124,176 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 2 | US$581.86 | 124,174 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 18 | US$583.37 | 124,156 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 63 | US$584.40 | 124,093 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 30 | US$585.42 | 124,063 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 58 | US$586.53 | 124,005 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 12 | US$587.64 | 123,993 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 32 | US$589.51 | 123,961 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 29 | US$590.77 | 123,932 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 7 | US$593.32 | 123,925 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 94 | US$577.37 | 4,514 | Indirect |
| Aug 7, 2026 | Common Stock | Sale | 114 | US$579.26 | 4,400 | Indirect |
| Aug 7, 2026 | Common Stock | Sale | 113 | US$580.71 | 4,287 | Indirect |
| Aug 7, 2026 | Common Stock | Sale | 113 | US$581.85 | 4,174 | Indirect |
| Aug 7, 2026 | Common Stock | Sale | 302 | US$583.35 | 3,872 | Indirect |
| Aug 7, 2026 | Common Stock | Sale | 1,035 | US$584.41 | 2,837 | Indirect |
| Aug 7, 2026 | Common Stock | Sale | 530 | US$585.44 | 2,307 | Indirect |
| Aug 7, 2026 | Common Stock | Sale | 945 | US$586.52 | 1,362 | Indirect |
| Aug 7, 2026 | Common Stock | Sale | 228 | US$587.64 | 1,134 | Indirect |
| Aug 7, 2026 | Common Stock | Sale | 522 | US$589.52 | 612 | Indirect |
| Aug 7, 2026 | Common Stock | Sale | 495 | US$590.78 | 117 | Indirect |
| Aug 7, 2026 | Common Stock | Sale | 117 | US$593.31 | 0 | Indirect |
Source
Related
- Thermo Fisher Scientific Inc
- Casper Marc N
- Thermo Fisher Scientific Inc shareholders
- Form 4 · Casper Marc N · Sep 1, 2026
- Form 4 · Casper Marc N · Aug 26, 2026
- Form 4 · Casper Marc N · Aug 24, 2026
- Form 4 · Casper Marc N · Aug 7, 2026
- Form 4 · Casper Marc N · Aug 7, 2026
- Form 4 · Pettiti Gianluca · Sep 1, 2026
- Form 4 · Meyer James · Sep 1, 2026
- Form 4 · Shafer Michael D · Sep 1, 2026
- Form 4 · Shropshire Thomas B Jr. · Sep 1, 2026
- Form 4 · Britt Lisa P. · Sep 1, 2026